More Efficient Tools to Realize Information for Consumers Act

Summary

Fair Accountability and Innovative Research Drug Pricing Act of 2019 or the FAIR Drug Pricing Act of 2019 This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

6 official files

• Reported in House (text)

  Reported in House · EN · 24 September 2019

  ViewDownloadOpen at official source

• Reported in House (PDF)

  Reported in House · EN · 24 September 2019

  ViewDownloadOpen at official source

• Reported to House

  summary · EN · 24 September 2019

  Open at official source

• Introduced in House (text)

  Introduced in House · EN · 12 April 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 12 April 2019

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 12 April 2019

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.